Dr Aloysius Nchinda

Senior Investigator | TB Chem

Aloysius T. Nchinda, Ph.D. is a Senior Investigator at H3-D

Drug Discovery and Development Centre at the University of Cape Town focused on Medicinal Chemistry, Hit-to-Lead and Lead Optimisation of Antimalarial and Anti-Tubercular agents. Nchinda received his Ph.D. degree in Chemistry from Rhodes University in South Africa and in April 2002 he pursued postdoctoral studies at the University of Cape Town. In 2005, Nchinda accepted a Research and Development Chemist position at Fine Chemical Corporation in Epping, Cape Town where he led the process chemistry team, which resulted in the development of two new commercial APIs in the company's product portfolio.

In late 2009, Nchinda moved to the University of Cape Town as a Chief Scientific Officer in Professor Kelly Chibale's research group in the Department of Chemistry. In addition to serving as the laboratory manager, Nchinda also served as Project Coordinator. He is also a member of the Royal Society of South Africa and the South African Chemical Institute. Nchinda is a co-inventor of 2 patents and was part of the project team that discovered the first ever preclinical candidate (MMV390048) to come from Africa as a single dose cure for malaria.